A Phase 2b Study Evaluating the Safety and Efficacy of AR-15512 Ophthalmic Solution for the Treatment of Dry Eye Disease
Clinical trial NCT04498182 · COMPLETED
Trial details
- NCT number
- NCT04498182
- Sponsor
- Aerie Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-26
- Primary completion
- 2021-07-17
- Enrollment
- 369
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.